08 Apr. 2019

ARE NOVEL ANTIBIOTICS WORTH INVESTING IN?


08 Apr. 2019

PRESS RELEASE - NEW CDO AT BIOVERSYS - DR. GLENN DALE

BioVersys is pleased to announce the appointment of Dr. Glenn Dale as Chief Development Officer as of February 1st, 2019.


08 Apr. 2019

FRESH FUNDS TO FUEL THE FIGHT AGAINST DRUG-RESISTANT BACTERIA

BioVersys together with BioSystems Technology and Voxcan announced funding - € 840,000 over a 3-year period - by Eurostars for IMPACT2, a new translat...


10 Apr. 2019

BIOSYSTEMS TECHNOLOGY, BIOVERSYS AND VOXCAN ANNOUNCE FUNDING BY EUROSTARS

BioSystems Technology, BioVersys and Voxcan announce funding for a total of about € 840’000, by Eurostars over a 3-year period for IMPACT2, a break-th...